Online ISSN: 3007-0244,
Print ISSN:  2410-4280
CURRENT TREATMENT OPTIONS FOR COVID - 19
The current pandemic of Coronavirus Disease 2019 (COVID-19) caused about 350 000 deaths in world. Currently, there are no proven effective vaccines or therapeutic agents against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Current clinical management includes supportive treatment and infection prevention and control measures. Research and clinical data regarding suggest a potential list of repurposed drugs with appropriate pharmacological effects and therapeutic efficacies in treating COVID-19 patients. In this review, we will update and summarize the most common and plausible drugs for the treatment of COVID-19 patients. These drugs and therapeutic agents include antiviral agents (favipiravir, remdesivir, hydroxychloroquine-chloroquine, lopinavir/ritonavir) and immunomodulatory agents (tocilizumab, tnf alpha inhibitors, corticosteroids, mesenchymal stem cell), among others.
Количество просмотров: 622

Ключевые слова:

Категория статей: Актуальная тема

Библиографическая ссылка

Eren E., Kiliç A.U. Current Treatment Options for COVID-19 // Nauka i Zdravookhranenie [Science & Healthcare]. 2020, (Vol.22) 3, pp. 5-11. doi 10.34689/SH.2020.22.3.001

Похожие публикации:

CURRENT TREATMENT OPTIONS FOR COVID - 19

Авторизируйтесь для отправки комментариев